A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
复制标题
DOI:
10.1016/j.ijrobp.2012.08.003
复制
发表时间:
2013-01-01
影响因子:
7
通讯作者:
Rosenstein, Barry S.
中科院分区:
文献类型:
--
作者:
Kerns, Sarah L.;Stock, Richard;Stone, Nelson;Buckstein, Michael;Shao, Yongzhao;Campbell, Christopher;Rath, Lynda;De Ruysscher, Dirk;Lammering, Guido;Hixson, Rosetta;Cesaretti, Jamie;Terk, Mitchell;Ostrer, Harry;Rosenstein, Barry S.
To identify single nucleotide polymorphisms (SNPs) associated with development of erectile dysfunction (ED) among prostate cancer patients treated with radiotherapy. A two-stage genome-wide association study (GWAS) was performed. Patients were split randomly into a stage I discovery cohort (132 cases, 103 controls) and a stage II replication cohort (128 cases, 102 controls). The discovery cohort was genotyped using Affymetrix 6.0 genome-wide arrays. The 940 top ranking SNPs selected from the discovery cohort were genotyped in the replication cohort using Illumina iSelect custom SNP arrays. 12 SNPs identified in the discovery cohort and validated in the replication cohort were associated with development of ED following radiotherapy (Fisher combined p-values 2.1×10−5 to 6.2×10−4). Notably, these 12 SNPs lie in or near genes involved in erectile function or other normal cellular functions (adhesion and signaling) rather than DNA damage repair. In a multivariable model including non-genetic risk factors, the odds ratios for these SNPs ranged from 1.6 to 5.6 in the pooled cohort. There was a striking relationship between the cumulative number of SNP risk alleles an individual possessed and ED status (Sommers’ D p-value = 1.7×10−29). A one-allele increase in cumulative SNP score increased the odds for developing ED by a factor of 2.2 (p-value = 2.1×10−19). The cumulative SNP score model had a sensitivity of 84% and specificity of 75% for prediction of developing ED at the radiotherapy planning stage. This GWAS identified a set of SNPs that are associated with development of ED following radiotherapy. These candidate genetic predictors warrant more definitive validation in an independent cohort.
登录
查看更多内容
影响因子:
45.3
作者:
Talcott, JA;Manola, J;D'Amico, AV
通讯作者:
D'Amico, AV
影响因子:
4.8
作者:
Witte, S;Villalba, M;Altman, A
通讯作者:
Altman, A
影响因子:
1.9
作者:
Zagar, Timothy M.;Stock, Richard G.;Stone, Nelson N.
通讯作者:
Stone, Nelson N.
影响因子:
2.1
作者:
Rosenstein BS
通讯作者:
Rosenstein BS
影响因子:
64.8
作者:
Gibbs, RA;Belmont, JW;Tanaka, T
通讯作者:
Tanaka, T